These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7474487)

  • 1. [Interferon induced IBD-like acute colitis--two cases of patients with chronic active hepatitis].
    Yamamoto Y; Sakatani N; Yano S; Kou K; Ochi S; Yoshida Y; Fujimoto R; Ohno K; Sawai S
    Nihon Shokakibyo Gakkai Zasshi; 1995 Sep; 92(9):1293-6. PubMed ID: 7474487
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical course of inflammatory bowel disease during treatment with interferon for associated chronic active hepatitis.
    Cottone M; Magliocco A; Trallori G; Brignola C; Vandelli C; Ardizzone S; Meucci G; Zannoni F; Di Maio G; Astegiano M
    Ital J Gastroenterol; 1995; 27(1):3-4. PubMed ID: 7795286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The treatment of hepatitis B and C with interferon-alpha can induce or aggravate psoriasis].
    Cervoni JP; Serfaty L; Picard O; Imbert JC; Poupon R
    Gastroenterol Clin Biol; 1995 Mar; 19(3):324-5. PubMed ID: 7781955
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of granulomatous hepatitis during treatment with interferon-alpha 2b.
    Propst A; Propst T; Dietze O; Kathrein H; Judmeier G; Vogel W
    Dig Dis Sci; 1995 Oct; 40(10):2117-8. PubMed ID: 7587776
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of chronic hepatitis B, C and D with alpha-interferon].
    Niederau C
    Fortschr Med; 1993 Feb; 111(6):35-7. PubMed ID: 8462911
    [No Abstract]   [Full Text] [Related]  

  • 6. [A case of chronic active hepatitis C presenting heart failure during interferon alpha 2 alpha therapy].
    Shinagawa J; Inagaki Y; Suzuki M; Atsukawa K; Yonei Y; Tsukada N; Miyamoto K; Suzuki O; Kawamura Y; Kiryu Y
    Nihon Shokakibyo Gakkai Zasshi; 1995 May; 92(5):899-903. PubMed ID: 7783385
    [No Abstract]   [Full Text] [Related]  

  • 7. Ischemic colitis during interferon-alpha treatment for chronic active hepatitis C.
    Tada H; Saitoh S; Nakagawa Y; Hirana H; Morimoto M; Shima T; Shimamoto K; Okanoue T; Kashima K
    J Gastroenterol; 1996 Aug; 31(4):582-4. PubMed ID: 8844482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why we should treat chronic viral hepatitis.
    King PD
    Postgrad Med; 1996 Sep; 100(3):68-70, 73; discussion 73, 78. PubMed ID: 8795647
    [No Abstract]   [Full Text] [Related]  

  • 9. [Interferon therapy in chronic viral hepatitis].
    Welland O
    Nord Med; 1992; 107(3):72-3, 75. PubMed ID: 1549455
    [No Abstract]   [Full Text] [Related]  

  • 10. Appearance of oral erosive lichen planus during interferon alfa-2a therapy for chronic active hepatitis C.
    Núñez M; Miralles ES; de las Heras ME; Ledo A
    J Dermatol; 1995 Jun; 22(6):461-2. PubMed ID: 7650248
    [No Abstract]   [Full Text] [Related]  

  • 11. Hazards of interferon therapy for HBV-seronegative chronic hepatitis.
    Vento S; Di Perri G; Garofano T; Cosco L; Concia E; Ferraro T; Bassetti D
    Lancet; 1989 Oct; 2(8668):926. PubMed ID: 2571851
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of transient autoimmune hepatitis during interferon treatment of chronic hepatitis B.
    Cianciara J; Laskus T
    Dig Dis Sci; 1995 Aug; 40(8):1842-4. PubMed ID: 7648989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zidovudine plus interferon alfa-2b treatment in patients with HIV and chronic active viral hepatitis.
    Visco G; Alba L; Grisetti S; Guarascio P; Narciso P; Sette P; Struglia C; Tossini G; Tozzi V
    Gut; 1993; 34(2 Suppl):S107-8. PubMed ID: 8314472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral erosive lichen planus with epidermolytic hyperkeratosis during interferon alfa-2b therapy for chronic hepatitis C virus infection.
    Schlesinger TE; Camisa C; Gay JD; Bergfeld WF
    J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):1023-5. PubMed ID: 9204077
    [No Abstract]   [Full Text] [Related]  

  • 15. The treatment of chronic viral hepatitis.
    Hoofnagle JH; di Bisceglie AM
    N Engl J Med; 1997 Jan; 336(5):347-56. PubMed ID: 9011789
    [No Abstract]   [Full Text] [Related]  

  • 16. Protection from clinical varicella disease during interferon alpha-2a therapy for chronic active hepatitis B infection.
    Curtiss D; Kaufman S; Harrison CJ
    Pediatr Infect Dis J; 1997 Jul; 16(7):720-2. PubMed ID: 9239783
    [No Abstract]   [Full Text] [Related]  

  • 17. Abducent nerve paralysis during interferon alpha-2a therapy in a case of chronic active hepatitis C.
    Fukumoto Y; Shigemitsu T; Kajii N; Omura R; Harada T; Okita K
    Intern Med; 1994 Oct; 33(10):637-40. PubMed ID: 7827383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of chronic hepatitis B and C.
    Dusheiko GM
    S Afr Med J; 1994 Aug; 84(8 Pt 2):563-70. PubMed ID: 7863401
    [No Abstract]   [Full Text] [Related]  

  • 19. [Attempted suicide during treatment of chronic viral hepatitis C with interferon. Apropos of 2 cases].
    Bourat L; Larrey D; Michel H
    Gastroenterol Clin Biol; 1995 Dec; 19(12):1063. PubMed ID: 8729421
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of chronic viral hepatitis].
    Marcellin P; Metreau JM; Pol S; Zoulim F
    Ann Gastroenterol Hepatol (Paris); 1996; 32(2):85-7. PubMed ID: 8737503
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.